BioStem Technologies Inc. Announces Issuance of Drug Enforcement Administration Registration for Qualified Pharma Ingredients
June 18, 2018 17:30 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, June 18, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies...
BioStem Technologies Inc. Enters Into Consulting and Advisory Agreement with Dr. Irmgard Huber
April 04, 2018 10:28 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, April 04, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with...
BioStem Technologies, Inc. Announces Letter of Intent with CCM Pharma Solutions to Co-Develop Multiple Solid to Liquid Dose Drugs Through 505(b)(2) Accelerated FDA Approval Process
March 26, 2018 19:22 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, March 26, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation providing innovative technologies with a...
BioStem Technologies Inc. Announces Engagement of Dr. Felix Amon for Pharmaceutical Business Development
March 13, 2018 18:16 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, March 13, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with...
BioStem Technologies Inc. Enter into Agreement with Barbara Krutchkoff, PhD. To Guide Scientific Affairs
March 09, 2018 17:09 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, March 09, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with...
BioStem Technologies Inc. Announces Intent to Acquire GIINT
February 26, 2018 20:27 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Feb. 26, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies...
BioStem Technologies Inc. Applies for Uplisting to the OTCQX Market
February 16, 2018 09:44 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Feb. 16, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies...
BioStem Technologies Inc. Announces New Transfer Agent, V Stock Transfer
February 09, 2018 10:39 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Pompano Beach, FL (GLOBE NEWSWIRE) – BioStem Technologies, Inc. (OTC PINK: BSEM) (the “Company”) announced today that it has changed the transfer...
BioStem Technologies Adds Chief Revenue Officer to Executive Team
February 08, 2018 17:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Feb. 08, 2018 (GLOBE NEWSWIRE) -- (GLOBE NEWSWIRE) – BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing...
BioStem Technologies, Inc. Announces the Engagement of Investment Banking Firm Young America Capital for 15 Million Dollar 506(c) Offering.
January 26, 2018 09:45 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Jan. 26, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BSEM” or “Company”) announced today the engagement of investment banking firm Young America Capital...